BioCardia, Inc. Earnings Per Share (Basic)
BioCardia, Inc. (BCDA) reported Earnings Per Share (Basic) of -$0.13 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- BioCardia, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.13.
- BioCardia, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.21.
- BioCardia, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.19.
- BioCardia, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.24.
- BioCardia, Inc. earnings per share, basic for fiscal 2025 was -$1.23.
- BioCardia, Inc. earnings per share, basic for fiscal 2024 was -$2.90.
- BioCardia, Inc. earnings per share, basic for fiscal 2023 was -$8.19.
- BioCardia, Inc. earnings per share, basic for fiscal 2022 was -$0.67.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.13 10-Q · filed 2026-08-12 | -$0.34 10-Q · filed 2026-08-12 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2026-03-31 | -$0.21 10-Q · filed 2026-05-15 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-12-31 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.23 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | -$0.24 10-Q · filed 2025-11-12 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.17 10-Q · filed 2025-11-12 | -$1.66 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-06-30 | -$0.40 10-Q/A · filed 2025-10-29 | -$0.98 10-Q/A · filed 2025-10-29 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.06 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-03-31 | -$0.59 10-Q · filed 2026-05-15 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.68 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.41 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2024-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$2.90 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | -$0.61 10-Q · filed 2025-11-12 | -$1.44 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$2.65 10-Q · filed 2025-11-12 | -$3.92 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-06-30 | -$0.88 10-Q/A · filed 2025-10-29 | -$2.20 10-Q/A · filed 2025-10-29 | -$3.55 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$5.27 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-03-31 | -$1.35 10-Q · filed 2025-05-14 | -$0.09 10-Q · filed 2024-05-14 | -$2.73 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$4.49 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$6.92 derived: net income ÷ weighted average shares · filed 2025-11-12 | |||
| 2023-12-31 | -$1.38 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$3.16 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$5.63 derived: net income ÷ weighted average shares · filed 2025-03-26 | -$8.19 10-K · filed 2025-03-26 | -$0.55 10-K · filed 2024-03-27 | |||
| 2023-09-30 | -$1.79 10-Q · filed 2024-11-13 | -$0.12 10-Q · filed 2023-11-08 | -$4.28 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$6.87 10-Q · filed 2024-11-13 | -$0.46 10-Q · filed 2023-11-08 | -$1.21 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||
| 2023-06-30 | -$2.52 10-Q · filed 2024-08-13 | -$0.17 10-Q · filed 2023-08-09 | -$5.12 10-Q · filed 2024-08-13 | -$0.34 10-Q · filed 2023-08-09 | -$0.75 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||
| 2023-03-31 | -$0.17 10-Q · filed 2024-05-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.65 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||||
| 2022-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$0.34 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$0.48 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$0.67 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$0.17 10-Q · filed 2023-11-08 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.51 10-Q · filed 2023-11-08 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||||
| 2022-06-30 | -$0.14 10-Q · filed 2023-08-09 | -$0.34 10-Q · filed 2023-08-09 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.70 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||||
| 2022-03-31 | -$0.19 10-Q · filed 2023-05-10 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.56 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.76 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||||
| 2021-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.75 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | -$0.16 10-Q · filed 2022-11-09 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.54 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | -$0.20 10-Q · filed 2022-08-10 | -$0.38 10-Q · filed 2022-08-10 | ||||||
| 2021-03-31 | -$0.18 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |